Material shortages make opportunity for theft

Pharmaceutical companies must pay close attention to their extended supply chains and the impact of the economy on other industries to develop strategies for dealing with raw material shortages, warns nonprofit supply chain group Rx-360. Such shortages are great opportunities for supply chain thieves to exploit. News Flash

Suggested Articles

A few years ago, one of our Fierce editors met a Big Pharma R&D chief for the first time. “You’re the ones with the scary name,” he joked.

AstraZeneca has signed a $750 million deal to produce up to 300 million doses of Oxford University's COVID-19 vaccine by year's end.

Racing with some COVID-19 vaccine heavyweights, Novavax has brought on a partner to manufacture adjuvant for its in-development shot.